MBTPS1 and neoplasm: In vitro studies have shown that neutralizing S1P with anti-S1P monoclonal antibodies inhibits neovascularization in multiple tumor cell lines which represents an impact that is less likely to be bypassed by production of alternative proangiogenic factors targeting tumor vessels (Visentin et al. 2006).